ABT

ABT Other Current Assets

$3.00BQuarterly · USD

Period ending:

ABT FY Other Current AssetsUSD
ABT FY Other Current Assets1985-12-31: $215.80M1986-12-31: $258.00M1987-12-31: $295.40M1988-12-31: $377.30M1989-12-31: $500.50M1990-12-31: $579.40M1991-12-31: $864.40M1992-12-31: $1.01B1993-12-31: $929.96M1994-12-31: $1.07B1995-12-31: $1.24B1996-12-31: $1.42B1997-12-31: $1.75B1998-12-31: $1.81B1999-12-31: $2.15B2000-12-31: $2.30B2001-12-31: $2.68B2002-12-31: $2.79B2003-12-31: $2.28B2004-12-31: $2.36B2005-12-31: $2.31B2006-12-31: $2.87B2007-12-31: $3.32B2008-12-31: $3.72B2009-12-31: $3.58B2010-12-31: $4.62B2011-12-31: $4.70B2012-12-31: $4.74B2013-12-31: $4.47B2014-12-31: $2.87B2015-12-31: $2.01B2016-12-31: $2.32B2017-12-31: $1.69B2018-12-31: $1.57B2019-12-31: $1.79B2020-12-31: $1.87B2021-12-31: $2.35B2022-12-31: $2.66B2023-12-31: $2.26B2024-12-31: $2.57B2025-12-31: $2.64B$4.74B$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ABT other current assets history

Current assets not classified elsewhere. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Abbott Laboratories Other Current Assets — Annual fiscal periods (USD)
Period endingOther Current Assets (USD)
2,640,000,000
2,570,000,000
2,256,000,000
2,663,000,000
2,346,000,000
1,867,000,000
1,786,000,000
1,568,000,000
1,687,000,000
2,319,000,000
2,013,000,000
2,867,000,000
4,470,000,000
4,743,000,000
4,703,246,000
4,620,821,000
3,575,025,000
3,721,425,000
3,323,588,000
2,870,885,000
2,311,162,000
2,358,945,000
2,276,144,000
2,786,973,000
2,680,887,000
2,298,741,000
2,145,175,000
1,810,200,000
1,745,900,000
1,423,700,000
1,237,035,000
1,074,290,000
929,955,000
1,006,900,000
864,400,000
579,400,000
500,500,000
377,300,000
295,400,000
258,000,000
215,800,000

Compare other current assets

All ABT financial metrics · ABT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.